drugset / Trial / NCT05666128
Efficacy and Safety of HD-6277 in Adult Patients with Inadequate Control of Type 2 Diabetes Mellitus by Diet and Exercise
RandomizedParallel-groupDouble-blindTreatment
Summary
A Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group, Phase 2 Study to Assess the Efficacy and Safety of HD-6277 in Adult Patients With Inadequate Control of Type 2 Diabetes Mellitus by Diet and Exercise
Timeline
- Start
- 2022-06-17
- Primary completion
- 2023-06-28
- Completion
- 2023-07-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HD-6277 | Unknown | 50 mg | — |
| Subject | HD-6277 | Unknown | 100 mg | — |